183 related articles for article (PubMed ID: 36819324)
1. A Case of Lepromatous Leprosy With Erythema Nodosum Leprosum.
Park L; Wallace CE; Vasile G; Buckley C
Cureus; 2023 Jan; 15(1):e33846. PubMed ID: 36819324
[TBL] [Abstract][Full Text] [Related]
2. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient.
Suryawati N; Saputra H
Int J Mycobacteriol; 2018; 7(2):191-194. PubMed ID: 29900900
[TBL] [Abstract][Full Text] [Related]
3. [Histoid leprosy with erythema nodosum leprosum].
Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
[TBL] [Abstract][Full Text] [Related]
4. Systemic manifestation of necrotic erythema nodosum leprosum: A case report of a fatal leprosy.
Maulida M; Vella V; Budini SS; Kamarlis RK; Junaidi F; Pradistha A; Bulqiah M
Narra J; 2023 Aug; 3(2):e216. PubMed ID: 38450265
[TBL] [Abstract][Full Text] [Related]
5. Cytological Diagnosis of Erythema Nodosum Leprosum in Clinically Unsuspected Cases: A Report of Two Cases.
Semwal S; Joshi D; Goel G; Mittal N; Majumdar K; Kapoor N
J Cytol; 2018; 35(1):63-65. PubMed ID: 29403176
[TBL] [Abstract][Full Text] [Related]
6. Erythema nodosum leprosum associated with minocycline.
Travassos AR; Antunes J; Pacheco D; Almeida LS; Filipe P; Marques MS
Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):39-41. PubMed ID: 23000940
[TBL] [Abstract][Full Text] [Related]
7. Persistent Infection Versus Type 2 Immunological Reaction in Lepromatous Leprosy.
Tanabe MB; Group AR; Rincon L; Stryjewska BM; Sarria JC
J Investig Med High Impact Case Rep; 2020; 8():2324709620927884. PubMed ID: 32462938
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Necrotizing Erythema Nodosum as a Manifestation of Lepromatous Leprosy Relapse 50 Years after the Initial Infection.
Galeano J; Contreras A; Pabón L; Ruiz AC; Serrano-Coll H; Arboleda M
Am J Trop Med Hyg; 2023 Jul; 109(1):53-56. PubMed ID: 37253443
[TBL] [Abstract][Full Text] [Related]
9. [Leprosy and the testis].
Rodríguez G; Abaúnza MC; Vargas EJ; López F
Biomedica; 2012; 32(1):13-22. PubMed ID: 23235783
[TBL] [Abstract][Full Text] [Related]
10. Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.
Mshana RN; Haregewoin A; Belehu A
J Clin Immunol; 1982 Apr; 2(2):69-74. PubMed ID: 7040440
[TBL] [Abstract][Full Text] [Related]
11. Erythema nodosum leprosum: reactional leprosy.
Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
[TBL] [Abstract][Full Text] [Related]
12. [Late diagnosis nodular lepromatous leprosy from the Peruvian Amazon, with development of a type 2 reaction].
Villegas-Chiroque M; Maldonado-Gómez W; Espino-Saavedra W; Ventura-Flores R
Rev Chilena Infectol; 2021 Oct; 38(5):707-712. PubMed ID: 35506839
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
Job CK; Jacobson RR; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
[TBL] [Abstract][Full Text] [Related]
15. Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.
Gupta SK; Kumari S
An Bras Dermatol; 2022; 97(1):49-53. PubMed ID: 34848113
[TBL] [Abstract][Full Text] [Related]
16. Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum.
Bansal F; Narang T; Dogra S; Vinay K; Chhabra S
Indian J Dermatol Venereol Leprol; 2018; 84(5):573-577. PubMed ID: 28656911
[TBL] [Abstract][Full Text] [Related]
17. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
[TBL] [Abstract][Full Text] [Related]
18. Late leprosy reaction presenting as erythema multiforme-like erythema nodosum leprosum with underlying rifampicin resistance and its potential implications.
Sardana K; Kulhari A; Mathachan SR; Khurana A; Bansal P; Ahuja A; Lavania M; Ahuja M
Int J Mycobacteriol; 2020; 9(2):226-228. PubMed ID: 32474551
[TBL] [Abstract][Full Text] [Related]
19. Erythema nodosum leprosum in Nigeria.
Somorin AO
Int J Dermatol; 1975 Nov; 14(9):664-6. PubMed ID: 1184260
[TBL] [Abstract][Full Text] [Related]
20. Leprosy, the Great Imitator of Rheumatic Diseases: A Case Study.
Youssef H; Mahani T; Hojjati M
Cureus; 2023 May; 15(5):e39527. PubMed ID: 37378226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
